Communication in process of R&D and registration of new drugs of traditional Chinese medicine / 中国中药杂志
China Journal of Chinese Materia Medica
;
(24): 730-735, 2021.
Artículo
en Chino
| WPRIM
| ID: wpr-878900
ABSTRACT
In recent years, the National Medical Products Administration has established a communication system for the process of drug R&D and registration. In this paper, the reform policies on establishing the communication system for drug evaluation in recent years were summarized, and the channels, processes, methods and types of communication were also collected. In addition, the communication status of new drugs of traditional Chinese medicine(TCM) was summarized according to the whole process of R&D, including summary of clinical practice, Investigational New Drug Applications, period of clinical trials, New Drug Applications, and post-marketing researches. Meanwhile, the current problems such as ineffective, inefficient, repeated or even no communication were analyzed, and relevant suggestions were proposed accordingly in order to provide reference for better communication on R&D and registration of new drugs of TCM.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Medicamentos Herbarios Chinos
/
Preparaciones Farmacéuticas
/
Comunicación
/
Medicina Tradicional China
Tipo de estudio:
Estudio diagnóstico
Idioma:
Chino
Revista:
China Journal of Chinese Materia Medica
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS